Abstract：AIM: To investigate the effect of chronic injection of L-thyroxine on Ca2+/calmodulin-dependent protein kinaseⅡ (CaMKII) and to explore whether CaMKII directly mediates hyperthyroidism-induced cardiac hypertrophy. METHODS: Twenty male Sprague-Dawley rats were randomly divided into hyperthyroid group and control group with 10 animals each. The animal model was produced by intraperitoneal injection of L-thyroxine (0.2 mg·kg-1·d-1) for 3 months. The control animals only received saline vehicle in the same procedures. Heart weight (HW), heart-to-body weight ratio (HW/BW), left ventricular-to-body weight ratio (LVW/BW) and diameter of cardiac myocytes were measured to evaluate cardiac hypertrophy. The ratio of perivascular collagen area to vascular luminal area (PVCA/VA) was used to represent myocrdial fibrosis. Moreover, the mRNA expression of CaMKII and the protein level of CaMKII were measured by real-time RT-PCR and Western blotting, respectively. RESULTS: Intraperitoneal injection of L-thyroxine for 3 months significantly increased HW/BW, LVW/BW, PVCA/VA and diameter of cardiac myocytes by 1.87, 1.84, 1.94 and 2.15 folds, respectively (P<0.05 or P<0.01) as compared with control group. The results of real-time RT-PCR revealed that L-thyroxine injection caused a 60% reduction in the mRNA level of cardiac CaMKII (P<0.05). Furthermore, the results of Western blotting confirmed that the protein expression level of cardiac CaMKII in L-thyroxine group diminished by 21% (P<0.05), but accompanied by a 1.58-fold enhancement of phosphorylated activity of CaMKII (P<0.05). CONCLUSION: Thyroxine decreases the expression level of cardiac CaMKII and increases the activity of CaMKII in the chronic hyperthyroid-induced hypertrophic heart, suggesting that CaMKII participates in the formation and maintenance of cardiac hypertrophy induced by hyperthyroidism in a balanced way.
李超, 刘善红, 张家明, 刘敏, 李景东. 长期甲状腺素刺激对大鼠心肌Ca /钙调蛋白依赖性蛋白激酶Ⅱ的影响[J]. 中国病理生理杂志, 2012, (1): 147-151.
LI Chao, LIU Shan-hong, ZHANG Jia-min, LIU Ming, LI Jing-dong. Effect of chronic administration of L-thyroxine on Ca2+/calmodulin-dependent protein kinaseⅡ in rat myocardium. Chin J Pathophysiol, 2012, (1): 147-151.
Arai M,Otsu K,MacLennan DH, et al. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins[J]. Circ Res, 1991, 69(2): 266-276.
[2]
Zhang T, Brown JH. Role of Ca2+/calmodulin-dependent protein kinase Ⅱ in cardiac hypertrophy and heart failure[J]. Cardiovasc Res, 2004, 63(3): 476-486.
[3]
Fazio S, Palmieri EA, Lombardi G, et al. Effects of thyroid hormone on the cardiovascular system[J]. Recent Prog Horm Res, 2004,59(1):31-50.
[4]
Kinugawa K, Jeong MY, Bristow MR, et al. Thyroid hormone induces cardiac hypertrophy in a thyroid hormone receptor α1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase[J]. Mol Endocrinol, 2005,19(6): 1618-1628.
[5]
Cao X, Kambe F, Moeller LC, et al. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts[J]. Mol Endocrinol, 2005,19(1): 102-112.
Kobori H, Ichihara A, Suzuki H, et al. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism[J]. Am J Physiol, 1997, 273(2 Pt 2): H593-H599.
[8]
Zhang R, Khoo MS, Wu Y, et al. Calmodulin kinase Ⅱ inhibition protects against structural heart disease[J]. Nat Med, 2005, 11(4):409-417.
[9]
Zhang T, Maier LS, Dalton ND, et al. The δC isoform of CaMK Ⅱ is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure[J]. Circ Res, 2003, 92(8): 912-919.
[10]
Wang W, Zhu W, Wang S, et al. Sustained β1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway[J]. Circ Res, 2004, 95(8):798-806.
Couchonnal LF, Anderson ME. The role of calmodulin kinase Ⅱ in myocardial physiology and disease[J]. Physiology, 2008, 23(3):151-159.
[13]
Erickson JR, Joiner MA, Guan X, et al.A dynamic pathway for calcium-independent activation of CaMKⅡ by methionine oxidation[J]. Cell, 2008, 133(3): 462-474.
[14]
Howe CJ, Lahair MM, McCubrey JA, et al. Redox regulation of the calcium/calmodulin dependent protein kinases[J]. J Biol Chem, 2004, 279(43): 44573-44581.
[15]
Jiang M,Xu A,Narayanan N. Thyriod hormone downregulates the expression and function of sarcoplasmic reticulum-associated CaM kinase Ⅱ in the rabbit heart[J]. Am J Physiol Heart Circ Physiol, 2006, 291(3): H1384-H1394.
[16]
Hoey A, Page A, Brown L, et al. Cardiac changes in experimental hyperthyroidism in dogs[J]. Aust Vet J, 1991, 68(11): 352-355.
[17]
Damiani E, Sacchetto R, Margreth A. Phosphorylation of anchoring protein by calmodulin protein kinase associated to the sarcoplasmic reticulum of rabbit fast-twitch muscle[J]. Biochem Biophys Res Commun, 2000, 279(1): 181-189.
[18]
Sacchetto R, Damiani E, Pallanca A, et al. Coordinate expression of Ca2+-ATPase slow-twitch isoform and of β calmodulin-dependent protein kinase in phospholamban-deficient sarcoplasmic reticulum of rabbit masseter muscle[J]. FEBS Lett, 2000, 481(3): 255-260.
[19]
Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts[J]. Cell, 2000, 101(4):365-376.
